Investors > About Vexim

Vexim Governance

Investors > About Vexim

Vexim Governance

Our Governance Board is composed by:

Vincent Gardès

Chief Executive Officer

Vincent Gardès holds a Bachelor of Arts in Business Administration from INSEEC Business School and a Post-Graduate Certificate in Leadership Capability from Glasgow Caledonian University. He speaks three languages (French, English and Spanish). Vincent Gardès began his career in 1995 at Stryker Spine as Product Manager for Europe. From 1996 to 1999, he held the position of Sales & Marketing Manager Knees & Spine at the Spanish subsidiary, Stryker Spain. Returning to France in 1999, he successively held the positions of Team Leader Hips for Stryker Europe, then Global Group Product Manager for Stryker Spine until 2002. At the end of 2002, Vincent Gardès joined the Medtronic Group, where he held the position of Spine Division Director for Europe. In 2004, he was promoted to Business Unit Manager Spine & Biologics, France, then in 2007, to Business Director for Southern Europe. Since September 2008, Vincent Gardès was CEO of CR Bard for Spain and Portugal, based in Barcelona. Starting in July 2011, he consulted for Vexim on behalf of Truffle Capital. Vincent Gardès was appointed Chief Executive Officer of Vexim in December 2011.

Vincent Gardès

Chief Executive Officer

Vincent Gardès holds a Bachelor of Arts in Business Administration from INSEEC Business School and a Post-Graduate Certificate in Leadership Capability from Glasgow Caledonian University. He speaks three languages (French, English and Spanish). Vincent Gardès began his career in 1995 at Stryker Spine as Product Manager for Europe. From 1996 to 1999, he held the position of Sales & Marketing Manager Knees & Spine at the Spanish subsidiary, Stryker Spain. Returning to France in 1999, he successively held the positions of Team Leader Hips for Stryker Europe, then Global Group Product Manager for Stryker Spine until 2002. At the end of 2002, Vincent Gardès joined the Medtronic Group, where he held the position of Spine Division Director for Europe. In 2004, he was promoted to Business Unit Manager Spine & Biologics, France, then in 2007, to Business Director for Southern Europe. Since September 2008, Vincent Gardès was CEO of CR Bard for Spain and Portugal, based in Barcelona. Starting in July 2011, he consulted for Vexim on behalf of Truffle Capital. Vincent Gardès was appointed Chief Executive Officer of Vexim in December 2011.

José Da Gloria

Chief Financial Officer & Executive Director

José Da Gloria is a university graduate of Versailles with a Master’s degree in Economy and Finance. Before joining Vexim as Chief Financial Officer and Executive Director in March 2014, he participated in the launch of a French start-up of cloud computing: Cloudwatt as head of Finance. José was, from 2010 till 2013, Financial controller of a $250 million International division at ev3, a US medical device company acquired in 2010 by Covidien, specialized in the vascular implants. He participated in the business development in the emerging countries (Latin America and Asia) as well as the financial, logistic and fiscal integration of the ev3 entities inside Covidien. Further to this integration, he integrated Covidien as the EMEA FP&A Director, a €2.5 billion Revenue. From 2008 till 2010, he was Finance Planning and Analysis manager and then Finance controller for the international division of ev3. He began his career in 2000 in the IT industry as FP&A analyst and took various finance and leadership roles inside Dell inc.

José Da Gloria

Chief Financial Officer & Executive Director

José Da Gloria is a university graduate of Versailles with a Master’s degree in Economy and Finance. Before joining Vexim as Chief Financial Officer and Executive Director in March 2014, he participated in the launch of a French start-up of cloud computing: Cloudwatt as head of Finance. José was, from 2010 till 2013, Financial controller of a $250 million International division at ev3, a US medical device company acquired in 2010 by Covidien, specialized in the vascular implants. He participated in the business development in the emerging countries (Latin America and Asia) as well as the financial, logistic and fiscal integration of the ev3 entities inside Covidien. Further to this integration, he integrated Covidien as the EMEA FP&A Director, a €2.5 billion Revenue. From 2008 till 2010, he was Finance Planning and Analysis manager and then Finance controller for the international division of ev3. He began his career in 2000 in the IT industry as FP&A analyst and took various finance and leadership roles inside Dell inc.

Russell Powers

Vice President and US General Manager

Russell brings more than 25 years of Medical Device experience in both the U.S. and International markets. Prior to VEXIM, Russell has served in various leadership roles with both NuVasive and Medtronic. Most recently Russell held the position of Executive Vice President of International and President of China for NuVasive. Prior to that, he served as Senior Vice President, Operations and Senior Vice President of Spinal and Biologics at NuVasive. During his 13 year-career at Medtronic, Russell held the positions of Vice President, U.S. Sales Operations, Vice President, International and various positions in Global Marketing. Russell began his career in orthopaedics and spine with Smith & Nephew as a member of the Trauma Marketing Group. Russell received a B.B.A from the Fogelman College of Business at the University of Memphis.

Russell Powers

Vice President and US General Manager

Russell brings more than 25 years of Medical Device experience in both the U.S. and International markets. Prior to VEXIM, Russell has served in various leadership roles with both NuVasive and Medtronic. Most recently Russell held the position of Executive Vice President of International and President of China for NuVasive. Prior to that, he served as Senior Vice President, Operations and Senior Vice President of Spinal and Biologics at NuVasive. During his 13 year-career at Medtronic, Russell held the positions of Vice President, U.S. Sales Operations, Vice President, International and various positions in Global Marketing. Russell began his career in orthopaedics and spine with Smith & Nephew as a member of the Trauma Marketing Group. Russell received a B.B.A from the Fogelman College of Business at the University of Memphis.

Gunther Peeters

Vice President Europe

With over 15 years of experience in the Healthcare Industry, he started working as a sales rep for Sandoz (Novartis Generics) moving to a territory manager function until making the transition into Medical devices in 2007, when he started at Spinal Kinetics, with their Artificial Disc Replacement technology, to enter the OUS markets. He was co-responsible for commercialising the products and build the business in all major markets with great success. In 2013, he accepted a new challenge with then R&D start-up, Orthobion GmbH, out of South-Germany. Orthobion GmbH is a development company for interbody fusion technology, that were treated with a specialized surface and nano-coating procedure. He was responsible for product-development, working closely with key EU surgeons alike, and setting a pathway for the company’s first commercial successes in the EMEA region. He graduated a Master in International Business Management at the Vlerick Business School, in Louvain/ Ghent, in partnership with London Business School, as well as other shorter term executive courses in Sales and Marketing. Gunther has extensive experience in commercialising innovative spine technology with which he helps provide benefit to the European Vexim business.

Gunther Peeters

Vice President Europe

With over 15 years of experience in the Healthcare Industry, he started working as a sales rep for Sandoz (Novartis Generics) moving to a territory manager function until making the transition into Medical devices in 2007, when he started at Spinal Kinetics, with their Artificial Disc Replacement technology, to enter the OUS markets. He was co-responsible for commercialising the products and build the business in all major markets with great success. In 2013, he accepted a new challenge with then R&D start-up, Orthobion GmbH, out of South-Germany. Orthobion GmbH is a development company for interbody fusion technology, that were treated with a specialized surface and nano-coating procedure. He was responsible for product-development, working closely with key EU surgeons alike, and setting a pathway for the company’s first commercial successes in the EMEA region. He graduated a Master in International Business Management at the Vlerick Business School, in Louvain/ Ghent, in partnership with London Business School, as well as other shorter term executive courses in Sales and Marketing. Gunther has extensive experience in commercialising innovative spine technology with which he helps provide benefit to the European Vexim business.

Sébastien Lemoine

Vice President International & Marketing

Sebastien joins Vexim from Tornier where he was Vice President for Large Joints, one of the three global business units of the company. During his tenure at Tornier he was responsible for the Hip & Knee business, accounting for 40m€ in sales. There he crafted and executed a successful strategy in more than 30 countries in collaboration with affiliates and distributors. His biggest success came in 2014 driving revenues up 10% in a flat market. Sebastien also served on corporate committees such as the Intellectual Property Board, Grants & Donations committee and Corporate Compliance Committee.
Prior to this role Sebastien was Business Unit Director Spine at Zimmer France. There he executed the integration following the acquisition of the Abbott Spine portfolio, and grew the business from €2.5m to €5m in two years. Before this assignment he was Director of Marketing at Zimmer France. Earlier Sebastien had a 10-year career at Stryker in various roles including R&D, European Marketing and Business Development. Sebastien brings a 19-year successful experience at both strategic and operational levels. He is graduated in mechanical engineering from SupMeca (Paris) and also holds a Master’s degree in Business Administration.

Sébastien Lemoine

Vice President International & Marketing

Sebastien joins Vexim from Tornier where he was Vice President for Large Joints, one of the three global business units of the company. During his tenure at Tornier he was responsible for the Hip & Knee business, accounting for 40m€ in sales. There he crafted and executed a successful strategy in more than 30 countries in collaboration with affiliates and distributors. His biggest success came in 2014 driving revenues up 10% in a flat market. Sebastien also served on corporate committees such as the Intellectual Property Board, Grants & Donations committee and Corporate Compliance Committee.
Prior to this role Sebastien was Business Unit Director Spine at Zimmer France. There he executed the integration following the acquisition of the Abbott Spine portfolio, and grew the business from €2.5m to €5m in two years. Before this assignment he was Director of Marketing at Zimmer France. Earlier Sebastien had a 10-year career at Stryker in various roles including R&D, European Marketing and Business Development. Sebastien brings a 19-year successful experience at both strategic and operational levels. He is graduated in mechanical engineering from SupMeca (Paris) and also holds a Master’s degree in Business Administration.

François Cathelineau

Vice President Operations

François Cathelineau starts his career in 2001 in the Aluminum industry at Pechiney, prior moving to the automotive industry as a manufacturing manager. He joins GE Healthcare in 2005, and holds several positions with increasing responsibilities within the manufacturing division, working in process, quality and operations management. In 2009, he takes the responsibility of an engineering product development program and leads his project team to launch a new mammography imaging system. He becomes France installation manager in 2011, supporting sales operations and looking after the whole Healthcare product portfolio. In 2014, he joins the global service supply chain leadership team as EMEA supply chain director, supporting a $1.4Bn service business.
François Cathelineau brings a successful 15-year experience in global operations management & product development, acquired in various industries. He graduated from Ecole MinesParisTech and Sciences-Po Paris.

François Cathelineau

Vice President Operations

François Cathelineau starts his career in 2001 in the Aluminum industry at Pechiney, prior moving to the automotive industry as a manufacturing manager. He joins GE Healthcare in 2005, and holds several positions with increasing responsibilities within the manufacturing division, working in process, quality and operations management. In 2009, he takes the responsibility of an engineering product development program and leads his project team to launch a new mammography imaging system. He becomes France installation manager in 2011, supporting sales operations and looking after the whole Healthcare product portfolio. In 2014, he joins the global service supply chain leadership team as EMEA supply chain director, supporting a $1.4Bn service business.
François Cathelineau brings a successful 15-year experience in global operations management & product development, acquired in various industries. He graduated from Ecole MinesParisTech and Sciences-Po Paris.

Board of Directors

Board of Directors

Financial Documents

Financial Documents